UPDATE : Friday, August 23, 2019
상단여백
NOAC race: Pradaxa prescription numbers fall behind fast followers by Marian Chu 2017-09-14 19:02
Opdivo vs. Keytruda - which will doctors choose? by Marian Chu 2017-09-14 17:54
Chong Kun Dang enters an osteoporosis therapy market by Lee Hye-seon 2017-09-14 17:53
AstraZeneca regains momentum with positive Imfinzi results by Marian Chu 2017-09-14 13:34
Amgen, Chong Kun Dang to sell osteoporosis drug in Korea by Marian Chu 2017-09-13 18:33
라인
Alvogen Korea to sell Vivus’ obesity drug by Marian Chu 2017-09-13 18:16
ASEAN officials visit JW’s manufacturing plant by Song Soo-youn 2017-09-13 18:07
Opdivo’s expanded indications ease cancer patients’ worries by Marian Chu 2017-09-13 16:57
Anticoagulant drugs will add SJS Warning by Lee Hye-seon 2017-09-13 15:55
Brokerage analyzes profit-sharing structure of Celltrion group by Nam Doo-hyun 2017-09-12 16:55
라인
EU approves Abbvie’s Humira as first biologic to treat CHMP by Marian Chu 2017-09-12 15:45
FIP head calls for revitalizing generic substitution by Lee Hye-seon 2017-09-12 14:34
Lilly’s diabetes drug ahead of Novo Nordisk’s in Q2 market share by Marian Chu 2017-09-12 13:26
Sillajen stock surges upon clinical trial announcement by Lee Han-soo 2017-09-12 13:26
Ildong, Olix agree to develop new drugs by Lee Han-soo 2017-09-11 17:30
라인
Abbvie lands 1st place on Dow Jones Sustainability Index by Marian Chu 2017-09-11 14:38
GSK’s HIV drug ranked No. 1 in Q2 sales by Marian Chu 2017-09-11 14:37
FDA orders halt on Opidvo trials by Marian Chu 2017-09-08 16:39
Vivus, Alvogen sign agreement to market diet treatment in Korea by Lee Han-soo 2017-09-08 15:24
Teva-Handok wins approval for anti-asthma injection by Marian Chu 2017-09-07 14:58
여백
여백
여백
Back to Top